Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail

P Pound, M Ritskes-Hoitinga - Journal of translational medicine, 2018 - Springer
Background The pharmaceutical industry is in the midst of a productivity crisis and rates of
translation from bench to bedside are dismal. Patients are being let down by the current …

[HTML][HTML] Reliability of common mouse behavioural tests of anxiety: A systematic review and meta-analysis on the effects of anxiolytics

M Rosso, R Wirz, AV Loretan, NA Sutter… - Neuroscience & …, 2022 - Elsevier
The validity of widely used rodent behavioural tests of anxiety has been questioned, as they
often fail to produce consistent results across independent replicate studies. In this study, we …

Conventional laboratory housing increases morbidity and mortality in research rodents: results of a meta-analysis

J Cait, A Cait, RW Scott, CB Winder, GJ Mason - BMC biology, 2022 - Springer
Background Over 120 million mice and rats are used annually in research, conventionally
housed in shoebox-sized cages that restrict natural behaviours (eg nesting and burrowing) …

Intracerebroventricular streptozotocin injections as a model of Alzheimer's disease: in search of a relevant mechanism

P Grieb - Molecular neurobiology, 2016 - Springer
Abstract Streptozotocin (STZ), a glucosamine-nitrosourea compound derived from soil
bacteria and originally developed as an anticancer agent, in 1963 has been found to induce …

Animal models of human disease: challenges in enabling translation

P McGonigle, B Ruggeri - Biochemical pharmacology, 2014 - Elsevier
Animal models have historically played a critical role in the exploration and characterization
of disease pathophysiology, target identification, and in the in vivo evaluation of novel …

Alzheimer's disease drug-development pipeline: few candidates, frequent failures

JL Cummings, T Morstorf, K Zhong - Alzheimer's research & therapy, 2014 - Springer
Introduction Alzheimer's disease (AD) is increasing in frequency as the global population
ages. Five drugs are approved for treatment of AD, including four cholinesterase inhibitors …

Mouse models of Alzheimer's disease

AM Hall, ED Roberson - Brain research bulletin, 2012 - Elsevier
Alzheimer's disease (AD) is the most common cause of dementia, affecting 35 million people
today. The search for new treatments is made ever more urgent by prospects for increasing …

APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes

J Zhao, MD Davis, YA Martens… - Human molecular …, 2017 - academic.oup.com
The ε4 allele of the APOE gene encoding apolipoprotein E (apoE) is a strong genetic risk
factor for aging-related cognitive decline as well as late-onset Alzheimer's disease (AD) …

Reengineering translational science: the time is right

FS Collins - Science translational medicine, 2011 - science.org
Despite dramatic advances in the molecular pathogenesis of disease, translation of basic
biomedical research into safe and effective clinical applications remains a slow, expensive …

Is animal research sufficiently evidence based to be a cornerstone of biomedical research?

P Pound, MB Bracken - Bmj, 2014 - bmj.com
Public acceptance of the use of animals in biomedical research is conditional on it
producing benefits for humans. Pandora Pound and Michael Bracken argue that the benefits …